Short Interest Reporting: AYTU BIOSCIENCE INC. COMMON STO (OTCMKTS:AYTU) Short Interest Increased By 378.01%

November 25, 2016 - By Adrian Mccoy   ·   0 Comments

Short Interest Reporting: AYTU BIOSCIENCE  INC. COMMON STO (OTCMKTS:AYTU) Short Interest Increased By 378.01%

The stock of AYTU BIOSCIENCE INC. COMMON STO (OTCMKTS:AYTU) registered an increase of 378.01% in short interest. AYTU’s total short interest was 67,400 shares in November as published by FINRA. Its up 378.01% from 14,100 shares, reported previously. With 111,500 shares average volume, it will take short sellers 1 days to cover their AYTU’s short positions. The stock closed at $1.15 during the last session. It is down 82.58% since April 22, 2016 and is downtrending. It has underperformed by 87.99% the S&P500.

Aytu BioScience, Inc. is a commercial-stage healthcare firm focused on acquiring, developing and commercializing products in the field of urology. The company has a market cap of $12.47 million. The Firm focuses on hypogonadism, prostate cancer, urinary tract infections and male infertility. It currently has negative earnings. The Firm markets ProstaScint , a radio imaging agent indicated to detect the prostate specific membrane antigen (PSMA) in the assessment and staging of prostate cancer.

AYTU Company Profile

Aytu BioScience, Inc., incorporated on June 3, 2015, is a commercial-stage healthcare firm focused on acquiring, developing and commercializing products in the field of urology. The Firm focuses on hypogonadism, prostate cancer, urinary tract infections and male infertility. The Firm markets ProstaScint (capromab pendetide), a radio imaging agent indicated to detect the prostate specific membrane antigen (PSMA) in the assessment and staging of prostate cancer. The Firm also markets Primsol (trimethoprim hydrochloride), a trimethoprim-only oral solution for urinary tract infections.

More notable recent Aytu Bioscience Inc (OTCMKTS:AYTU) news were published by: Prnewswire.com which released: “Aytu BioScience Announces Pricing of $8.6 Million Public Offering of Common …” on October 27, 2016, also Prnewswire.com with their article: “Aytu BioScience Announces Study Collaboration with Hybridyne Imaging …” published on March 01, 2016, Prnewswire.com published: “Aytu BioScience to Execute Reverse Stock Split in Anticipation of Uplisting …” on June 22, 2016. More interesting news about Aytu Bioscience Inc (OTCMKTS:AYTU) were released by: Streetinsider.com and their article: “Aytu BioScience (AYTU) Announces Publication of Significant MiOXSYS Data” published on November 17, 2016 as well as Prnewswire.com‘s news article titled: “Rosewind Corporation to Become Aytu BioScience, Inc.” with publication date: June 02, 2015.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By Adrian Mccoy


Readers Comments (0)





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>